ADC Therapeutics announced a comprehensive financial restructuring that includes an $86.6 million private placement, amendments to its HealthCare Royalty agreement, and a refinancing of its senior secured loan. The company said the combined transactions are designed to strengthen its balance sheet, reduce leverage, increase strategic flexibility, and extend its expected cash runway into 2029.